Razadyne ER: FDA Approved Extended Treatment for Alzheimer's Dementia - Associated ContentEach day, families across the United States are struck with the diagnosis that a loved one suffers from Alzheimer's dementia. For both men and women who suffer, this progressive disease marks the beginning of a long and complicated battle in the lateIn an effort to remedy the complications associated with Alzheimer's dementia, Ortho-McNeil Neurologics, Inc., has released an extended release FDA approved drug, Razadyne ER, to aide Alzheimer's patients in regaining some control over the irregular pattern of loss of memory and provide, to some extent, a restoration to a somewhat normal, active and healthy life. For patients who suffer from a mild to moderate Alzheimer's dementia, appropriate testing should be completed to confirm the diagnosis and rule out other complicating health factors. When confirmed as mild to moderate, age-related, Alzheimer's dementia, Razadyne ER may provide the relief needed.